(R)-tert-butyl 3-methyl-5-oxopiperidine-1-carboxylate, 95%, 100mg

3-[1,2,4]Triazol-1-yl-propionic acid, 95.0%, 5g

Methyl alpha-L-Fucopyranoside>98.0%(HPLC)1g

4-(2-Aminoethyl)pyridine, 95.0%, 5g

2-Chloromethyl-3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridine hydrochloride, 97.0%, 100g

3-Methoxy-2,4,5-trifluorobenzonitrile, 97.0%, 5g

4-Bromo-2-chloro-5-fluoroaniline, 95.0%, 5g

2,3-Dichlorobenzoic acid, 97.0%, 25g

2-o-Tolyloxy-ethylamine, 95.0%, 5g

N-(2,5-dimethoxyphenyl)acetamide, 95+%, 5g

2-Chloro-n-cyclohexyl-n-ethylacetamide, 98%, 250mg

5-Iodo-N,N-dimethylpyridin-2-amine, 95.0%, 5g

Diacetone alcohol, min. 98%, for synthesis, 2.5 L, glass packaging